Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety
暂无分享,去创建一个
J. Sakamoto | K. Oba | Kenji Kobayashi | Masazumi Takahashi | K. Ishibashi | M. Honda | Takeshi Kato | H. Mishima | C. Matsuda | H. Satake | Y. Munemoto | C. Tanaka | K. Nakata | Y. Morita | H. Tanioka | M. Kataoka